The Randomized Controlled Trial Study of the Incidence of Paclitaxel Hypersensitivity Reaction as First Line drug in Gynecologic Cancer Patients between 2 Steroid Premedication Type: Hydrocortisone & dexamethasone VS Dexamethasone alone
Not Applicable
Completed
- Conditions
- Gynecologic cancer patients who had not been received paclitaxel therapy.Hypersensitivity reactionPaclitaxelhypersensitivity reactionanaphylaxisPremedicationHydrocortisoneDexamethasone
- Registration Number
- TCTR20151122001
- Lead Sponsor
- none
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Female
- Target Recruitment
- 52
Inclusion Criteria
1.Gynecologic cancer patient who had pathology report
2.Need paclitaxel therapy
3.Patient who had not been received paclitaxel
4.Bone marrow, kidney,and liver were with in normal limit
Exclusion Criteria
1.allergy to hydrocortisone
2.patient who had been received paclitaxel
3.patient who had history of paclitaxel allergy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Incidence of hypersensitivity reaction during intravenous paclitaxel infusion medical record about hypersensitivity reaction during intravenous paclitaxel infusion
- Secondary Outcome Measures
Name Time Method none none none